Marzena Furtak-Niczyporuk

Profesor uczelni

Gdański Uniwersytet Medyczny

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Cancer Biology Cancer Biology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (7)

Anna Jamroz-Wisniewska

assistant professor

Medical University of Lublin

POLAND

View details

Robert Sitarz

Medical University of Lublin

POLAND

View details

Grzegorz Teresiński

Medical University of Lublin

POLAND

View details

Grzegorz Buszewicz

Professor, Chief of Laboratory of Forensic Toxicology

Medical University of Lublin

POLAND

View details

Łukasz Poniatowski

Medical University of Warsaw

POLAND

View details

Przemyslaw Puz

POLAND

View details

Bożena Adamczyk

Medical University of Silesia

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marzena Furtak-Niczyporuk

Research Interests

Explore related searches

Contact this professor

Articles (13)

AOTMiT reimbursement recommendations compared to other HTA agencies

The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme

Colorectal Cancer—The Worst Enemy Is the One We Do Not Know

The impact of changing the funding model for genetic diagnostics and improved access to personalized medicine in oncology

Two years of the COVID-19 pandemic from a child’s perspective: A narrative review

Epidemiological features and changes in the occurrence of infectious diseases in Poland from 2015 to 2020 in the context of the emerging novel SARS-CoV-2 (COVID-19) pandemic

Reverse Drug Distribution Chain: Analysis of the Phenomenon

Biomarkers and genetic markers of hepatocellular carcinoma and cholangiocarcinoma-what do we already know

Modified rio score with platform therapy predicts treatment success with fingolimod and natalizumab in relapsing-remitting Multiple Sclerosis patients.

A systematic review of the cyclooxygenase-2 (COX-2) expression in rectal cancer patients treated with preoperative radiotherapy or radiochemotherapy

Economic Costs of Cardiovascular Diseases in Poland Estimates for 2015–2017 Years

Overview and Analysis of the Cost of Drug Programs in Poland: Public Payer Expenditures and Coverage of Cancer and Non-Neoplastic Diseases Related Drug Therapies from 2015–2018 Years

Decreased cerebrospinal fluid orexin-A (hypocretin-1) concentrations in patients after generalized convulsive status epilepticus

Collaborators (7)

Anna Jamroz-Wisniewska

Robert Sitarz

Grzegorz Teresiński

Grzegorz Buszewicz

Łukasz Poniatowski

Przemyslaw Puz

Bożena Adamczyk

Make your next move.